Top highlights from ASCO & EHA 2023

ASCO/EHA 2024 Myeloma Highlights | Ajai Chari, MD | EHA 2024Подробнее

SCD highlights from EHA 2023: the biology of pain crises & Solace-kidsПодробнее

EHA and ASCO 2023 highlights: promising treatments in AML, MDS, and ALLПодробнее

EHA 2023 | RedirecTT-1Подробнее

Highlights from ASCO 2024Подробнее

ASCO 2023 HighlightsПодробнее

What’s New In Diffuse Large B-Cell LymphomaUpdates from ASCO 2024 & the EHA Hybrid CongressПодробнее

Highlights at ASCO 2023Подробнее

Top highlights from ASCO & EHA 2023Подробнее

Highlights from ASCO / EHA 2021: latest updates on myelomaПодробнее

ASCO 2023: Highlights and analysisПодробнее

All set Best of Asco 2023 #BOA2023Подробнее

ASCO GI 2023 highlights: AI in gastrointestinal cancersПодробнее

Top Multiple Myeloma Research Presented at ASCO and EHA 2023Подробнее

EHA 2023 HighlightsПодробнее

ASCO 2023 Highlights on nivolumab in advanced stage classic Hodgkin Lymphoma: the SWOG S1826 studyПодробнее

ASCO 2023 Highlights on the MIRASOL trial in PT-resistant adv. high-grade epithelial Ovarian CancerПодробнее

Hot Topics In Non-Hodgkin Lymphoma: Updates from ASCO 2024 & the EHA Hybrid CongressПодробнее

EHA 2023 CLL highlightsПодробнее